Calls
15
#1216
Alpha Score 33.5
Bae Jae-won
Private Banker, Incheon Branch
Win Rate
26.7%
return
+0.3%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$177700.00
-53.2%
JP Morgan Healthcare and the expanding obesity/metabolic pipeline keep attention on Korean biotech. Korean biotech technology exports have topped 20 trillion won and licensing-out deals are increasing in number and size, with Alteogen, LigaChem Bio, and ABL Bio as examples; bio must help lead KOSDAQ higher alongside KOSPI.
Pharma & Biotech
Long
Jan 12
$481000.00
-47.2%
JP Morgan Healthcare and the expanding obesity/metabolic pipeline keep attention on Korean biotech. Korean biotech technology exports have topped 20 trillion won and licensing-out deals are increasing in number and size, with Alteogen, LigaChem Bio, and ABL Bio as examples; bio must help lead KOSDAQ higher alongside KOSPI.
Pharma & Biotech
Long
Jan 12
$123.93
+27.5%
JP Morgan Healthcare and the expanding obesity/metabolic pipeline keep attention on Korean biotech. Korean biotech technology exports have topped 20 trillion won and licensing-out deals are increasing in number and size, with Alteogen, LigaChem Bio, and ABL Bio as examples; bio must help lead KOSDAQ higher alongside KOSPI.
Thematic ETFs
Showing 3 of 15 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Bae Jae-won has 15 trade ideas tracked on Buzzberg across 15 tickers since January 2026. Win rate 27% across 15 evaluated calls, average return +0.3%. Ranked #1216 on the Buzzberg Alpha leaderboard. Most covered: 000660.KS, 005930.KS, 012450.KS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
